Implementation of functions in R tool in parallel environment by Makris, Antonios
 HAROKOPION UNIVERSITY OF ATHENS 
DEPARTMENT OF INFORMATICS & TELEMATICS 
 
 
 
 
Master Thesis Title: 
 
IMPLEMENTATION OF FUNCTIONS IN R TOOL IN 
PARALLEL ENVIRONMENT 
 
 
 
 
Supervisor  
Konstantinos Tserpes, Lecturer 
Supervisory Committee 
Iraklis Varlamis, Assistant Professor 
Dimitrios Michail, Assistant Professor 
 
 
 
 
 
              Antonios Makris(Id.N.: 13108) 
MSc candidate in Web Engineering 
BSc in Informatics and Telematics 
 
 
 
 
Athens, July 2015 
1 
Acknowledgements 
As the author of this thesis, i would like to express my sincere appreciation to all 
those who assisted and supported me in the preparation of this master thesis as 
well as throughout my studies in general. 
 
I would like to thank the supervisor of my thesis and Lecturer at the Department of 
Informatics & Telematics in Harokopio University Kostantino Tserpe , the Assistant 
Professor Irakli Varlami and Assistant Professor Dimitrio Michail, for their 
assistance and substantial help in the completion of my thesis, the excellent 
collaboration, the valuable guidance and knowledge and for the strong support and 
confidence. Also, I would like to thank them for the opportunity they gave me to 
work on research issues and expand my horizons. 
 
Finally, I would like to thank my family and friends for their support throughout 
my studies and for their understanding and patience. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2 
Abstract 
Drug promiscuity and polypharmacology are much discussed topics in 
pharmaceutical research. Drug repositioning applies established drugs to new 
disease indications with increasing success. As polypharmacology, defined a drug’s 
ability to bind to several targets but due to possible side effects, this feature is not 
taken into consideration. Thus, the pharmaceutical industry focused on the 
development of highly selective single-target drugs. Nowadays after lot of researches, 
it is clear that polypharmacology is important for the efficacy of drugs. There are side 
effects but on the other hand, this gives the opportunity to uncover new uses for 
already known drugs and especially for complex diseases. Thus, it is clear that there 
are two sides of the same coin. 
 
There are several approaches to discover new drugs targets, as analysis of genome 
wide association, gene expression data and networks, structural approaches with 
alignment methods etc. Computational drug discovery and design has experienced a 
rapid increase in development which is mainly due to the increasing cost for 
discovering new compounds. Since drug development is a very costly venture, the 
pharmaceutical industry puts effort in the repositioning of withdrawn or already 
approved drugs. The costs for bringing such a drug to market are 60% lower than the 
development of a novel drug, which costs roughly one billion US dollars. Thus, target 
prediction, drug repositioning approaches, protein-ligand docking and scoring 
algorithms, virtual screening and other computational techniques have gained the 
interest of researchers and pharmaceutical companies.   
 
According to researches, drug repositioning process makes use of technologies and 
algorithms based on sequential programming. Thus it presents research interest the 
parallelization of such procedures, in order to make improvements in the accuracy 
and performance of the system in comparison to the current art. 
 
Keywords: Drug promiscuity, Polypharmacology, Binding site, Structural 
Alignment, Protein Structures, Parallelization, Isomorphism, Sequence Alignment 
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Abstract in Greek 
Η “ασυδοσία” των φαρμάκων και η πολυφαρμακολογία, αποτελούν πολυσυζητημένα 
θέματα στη φαρμακευτική έρευνα. Η επανατοποθέτηση φαρμάκων εφαρμόζεται στα 
ήδη υπάρχοντα φάρμακα για την ένδειξη ασθενειών, με αυξανόμενη επιτυχία. Ως 
πολυφαρμακολογία, ορίζεται η ικανότητα ενός φαρμάκου να συνδέεται με 
διάφορους στόχους αλλά λόγω πιθανών παρενεργειών, αυτό το χαρακτηριστικό δεν 
είχε ληφθεί σοβαρά υπόψη. Έτσι, η φαρμακευτική βιομηχανία επικεντρώθηκε στην 
ανάπτυξη φαρμάκων μοναδικού στόχου. Σήμερα μετά από έρευνες, είναι σαφές ότι η 
πολυφαρμακολογία είναι σημαντική για την αποτελεσματικότητα των φαρμάκων. 
Υπάρχουν παρενέργειες, αλλά από την άλλη πλευρά, δίνεται τη δυνατότητα 
ανακάλυψης νέων χρήσεων για ήδη γνωστά φάρμακα και ειδικά για πολύπλοκες 
ασθένειες. Έτσι είναι σαφές, ότι υπάρχουν δύο όψεις του ίδιου νομίσματος. 
 
Υπάρχουν διάφορες προσεγγίσεις για την ανακάλυψη νέων στόχων όσο αφορά τα 
φάρμακα, όπως η ανάλυση του γονιδιώματος σε επίπεδο σύνδεσης, γονιδιακά 
δεδομένα έκφρασης και δίκτυα, δομικές προσεγγίσεις με μεθόδους ευθυγράμμισης 
κτλ. Η υπολογιστική ανακάλυψη φαρμάκων και ο σχεδιασμός αυτών, γνώρισε 
ραγδαία ανάπτυξη, η οποία οφείλεται κυρίως στο αυξημένο  κόστος, για την 
ανακάλυψη νέων ενώσεων. Δεδομένου ότι η ανάπτυξη φαρμάκων είναι μια πολύ 
δαπανηρή διαδικασία, η φαρμακευτική βιομηχανία έχει επικεντρωθεί στην 
επανατοποθέτηση αποσυρθέντων ή ήδη εγκεκριμένων φαρμάκων.  Οι δαπάνες για 
την δημιουργία και διοχέτευση ενός τέτοιου φαρμάκου στην αγορά είναι 60% 
χαμηλότερες από την ανάπτυξη ενός νέου, το οποίο κοστίζει περίπου ένα 
δισεκατομμύριο δολάρια. Έτσι προσεγγίσεις που αφορούν, την επανατοποθέτηση 
φαρμάκων,  την πρόβλεψη πρωτεϊνικών στόχων, τους αλγόριθμους σύνδεσης, την  
βαθμολόγηση πρωτεΐνης-προσδέτη και άλλες υπολογιστικές τεχνικές έχουν κερδίσει 
το ενδιαφέρον των ερευνητών και των φαρμακευτικών εταιρειών. 
 
Σύμφωνα με έρευνες, η διαδικασία επανατοποθέτησης φαρμάκων επιτυγχάνεται 
μέσω τεχνολογιών και αλγορίθμων, που βασίζονται στον σειριακό προγραμματισμό. 
Έτσι παρουσιάζει ερευνητικό ενδιαφέρον, η παραλληλοποίηση αυτών των 
διαδικασιών με σκοπό την βελτίωση της ακρίβειας και της απόδοσης του 
συστήματος, σε σύγκριση με την τρέχουσα τεχνολογία. 
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1. Introduction - The problem 
Drug discovery and development is a complex and expensive process. Due to the 
exponential growth of protein and molecular data and fast advancement in 
technologies, the efforts of drug discovery have been tremendously amplified. 
      
Early efforts in drug discovery relied on screening natural products derived from 
plants and microorganisms and testing them for activity in animal models. This was 
a slow and labour-intensive process carried out mostly in the wet lab.    
 
Computational drug discovery and design has experienced a rapid increase in 
development which is mainly due to the increasing cost for discovering new 
compounds. According to researches the cost for producing a new drug is estimated 
to have grown at an annual compound rate of 13.4% since the 1950s. The cost for 
developing a new drug is on average 4 billion US$ and requires 15 years until it 
reaches the market. The clinical trials are the most expensive stages in this process. 
However, the research for a target that links to a disease and a molecule that 
modulates the function of target without side effects mostly influences approval at 
early stages and increases the clinical target validation success rate. As a result target 
prediction, drug repositioning approaches, protein-ligand docking and scoring 
algorithms, virtual screening and other computational techniques have gained the 
interest of researchers and pharmaceutical companies.   
 
The most recent and successful research on drugs repositioning, makes use of 
technologies and algorithms based on sequential programming.  
 
Generally in this study, we investigate technologies which tackle the problem of the 
identification of structurally similar proteins in order to identify new purposes for 
the use of drugs. The current study, aims at identifying combinations of proteins that 
may have similarities with a view to repositioning them. We implement a solution 
based on Open Message Passing Interface (OpenMPI) with the purpose to make 
improvements in the accuracy and performance of the system in comparison to the 
current art. 
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The main plan is to conduct experiments based on the pipeline algorithms proposed 
by Haupt et al (2013).  These pipeline algorithms were executed sequentially and for 
specific inputs. Our goal is to parallelize the whole process but also part of this in 
order to improve the execution speed, avoid bottlenecks and extract quickly results.  
 
The key-concept of the advances that this work brings is based on the performance of 
simulations of computational drug-target predictions. Drug-target binding 
simulations aim at the advancement of medical and biological knowledge at a fast 
pace and a low cost.  
 
1.1 Structure 
Section 2 presents the current state of the art system and technologies for the 
Binding Site Similarity process. 
Section 3 presents the design of our system in general, the technologies used, the 
packages and libraries that installed and the architecture of the system. 
Section 4 presents the implementation conducted, the functions that used and the 
parallelization of both levels of the BSS pipeline. 
Section 5 presents the results of experiments. In general, compared and represented 
the execution time among different setups and levels of parallelization. 
Section 6 presents the conclusion of this study and the future work plans. 
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2. Related Work 
2.1 Introduction - Drug Promiscuity 
Drug repositioning applies established drugs to new disease indications with 
increasing success. A prerequisite for drug repurposing is drug promiscuity 
(polypharmacology) ie a drug’s ability to bind to several targets. Drug promiscuity 
remains an open issue and hydrophobicity and molecular weight have been 
suggested as key reasons. Protein structures offer a structural dimension to explain 
promiscuity and here raises the question if a drug bind multiple targets because it is 
flexible or because  the targets are structurally similar or share similar binding sites. 
[11] 
 
Developing a drug in laboratory is a laborious and costly endeavor. Thus, the 
repositioning of already approved drugs for the treatment of new diseases is 
promising and valuable. One computational approach to repositioning exploits the 
structural similarity of binding sites of known and new targets and also reduces costs 
and improves efficiency. So, the pharmaceutical industry puts effort in the 
repositioning of withdrawn or already approved drugs. The costs for bringing such a 
drug to market are 60% lower than the development of a novel drug, which costs 
roughly one billion US dollars. Drug repositioning is the process of finding new 
indications for existing drugs. Beside the lower drug development costs and the 
reduced time for approval, a new drug application can help to expand the patent life 
and increase the return for the investment in the development of the drug. [12] 
 
Binding sites are closely related to protein function. Τhe identification of binding 
sites in proteins is essential to the understanding of their interactions with ligands, 
including other proteins. Binding sites can retain conservation of sequence and 
structure. Structural conservation however is more prevalent. Even in the absence of 
obvious sequence similarity, structural similarity between two protein structures can 
imply common ancestry, which in turn can suggest a similar function. [13] 
 
Drug repurposing is supported by the core observation that a single drug often 
interacts with multiple targets. It offers an appealing strategy and enables reuse of 
existing therapeutic compounds. Predicting off-targets by computational methods is 
gaining increasing interest in early-stage drug discovery.  When a similar binding site 
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is detected in the Protein Data Bank (PDB), it is possible that the corresponding 
ligand also binds to that similar site. This target hopping case is probably rare 
because it requires a high similarity between the binding sites and on the other hand, 
it could be a strong rationale evidence to highlight possible off-target reactions and 
possibly a potential undesired side effect. This target-based drug repurposing can be 
extended a significant step further with the capability of searching the full surface of 
all proteins in the PDB, and therefore not relying on pocket detection. Resolved 3D 
protein structures are a major source of information for understanding protein 
functional properties. The current explosive growth of publicly available protein 
structures in the Protein Data Bank (PDB) is producing massive volumes of data for 
computational modeling and drug design methods. [14] 
 
The prerequisite for drug repositioning is polypharmacology (drug promiscuity), 
meaning that one drug binds to multiple distinct targets. Recent researches have 
shown that promiscuity of proteins in ligand binding as well as in function is not as 
rare as previously thought. There is an enormous potential to find novel targets for 
already known drugs based on the approved targets since promiscuous drugs are 
common. If a drug target defined as a protein to which a drug molecule binds 
physically, there are about 320 known targets for approved drugs. By applying a 
more loose definition and including experimental drugs can easily lead to 6000 or 
more drug targets. A study of a data set of 276.122 bioactive compounds revealed 
that 35% of them are known to bind to more than one target. A quarter of these was 
found to bind to proteins from different gene families. 
 
The permissive binding of a drug to off-targets can be the cause of adverse side 
effects but may in contrast also increase its efficacy. Similarities in the key 
pharmacophores of structurally different proteins can lead to high affinity binding of 
the same drug. According to researches, one way to identify promiscuous proteins is 
chemocentric, which exploits chemical similarity among the ligands but this 
approach is weakened because chemical similarity seems to contribute much less to 
similarity in the biological activity profile. Another method is the binding site centric 
chemical space. To find new targets leading to repositioning drugs there are the 
following techniques: a) Non-in silico, b) In vitro, c) In silico and should apply a 
combination thereof, in order to extract correct results. [12] 
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2.2 Binding Site Similarity (BSS) 
Earlier, a drug binding to multiple different targets was unwanted in drug 
development due to possible side effects. For this reason, the pharmaceutical 
industry focused on the development of highly selective single-target drugs. 
Nowadays, it is clear that polypharmacology (drug promiscuity), is important for the 
efficacy of drugs. This gives the opportunity to uncover new uses for already known 
drugs and increase the efficacy of drugs. There are efforts to develop promiscuous 
drugs, especially for complex diseases. Approaches to discover new drug targets and 
uses are manifold, ranging from the analysis of genome wide association studies, 
gene expression data and networks to structural approaches. Structural binding site 
comparison approaches can be distinguished in alignment methods and alignment-
free methods. These methods have the advantage of uncovering also distant 
similarities but do not provide an aligned structure. [11] 
 
According to researches, there is no correlation between drug promiscuity and 
molecular weight or hydrophobicity. A drug may be promiscuous for reasons of 
structural nature. This means that a drug may be flexible and can bind to different 
binding sites or the binding sites of the targets may be similar as shown in Figure 2.1 
below. 
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                  Figure 2.1 Drug promiscuity: Ligand flexibility vs binding site similarity (Haupt et al., 2013) 
 
For the needs of this research, there were selected 543 drugs from PDB and 164 of 
those with three or more targets. These drugs bind a set of 712 non-redundant 
protein structures and clustered by 95% sequence identity. 
 
To investigate whether a protein's pair has a similar binding site, SMAP align locally 
their structures. Initially, it made selection of the Ca atoms from each protein and 
13 
then found the local superposition of these atoms in space. Ligand positions were 
used to evaluate alignment, since only binding sites of identical promiscuous drugs 
are aligned against each other. Ligand positions can be found, by measuring 
distances between the atoms of the ligands (RMSD) that we examine. Subsequently, 
it conducted an automated substructure search using SMSD (Small Molecule 
Subgraph Detector), generating a robust scoring for binding site similarity: 
LigandRMSD. The pipeline that shows whether promiscuous drugs have targets with 
similar binding sites affected in these steps: 
 
1. Alignment of all pairs of binding sites for all promiscuous drugs using SMAP  
2. Removing redundant targets 
3. Keeping sites with a consistent binding mode of the ligand 
 
In step 1 it conducted comparison of any possible match of binding sites in a 
promiscuous drug. Since the comparison is pair wise, the number of 712 non-
redundant targets (2284 structures) leads to a total 38244 aligned binding site pairs. 
 
In step 2 redundant targets removed by clustering targets with 95% sequence 
identity. This is important because some of the aligned binding sites are very similar 
and thus it reduced the dataset to nearly 10% (3948 pairs) 
 
In step 3 it conducted comparisons between the ligands, since it is vital that the 
compared binding sites, bind the ligand in a similar mode. This step is called 
LigandRMSD and made a computation of how well the two ligands of the compared 
binding sites are aligned due to the superposition of the binding sites, by measuring 
the RMSD of the ligand superposition and comparing it to a corresponding optimal 
superposition. The alignment of two binding sites is successful if the positions of 
their shared ligand in each site are similar. Thus this step reduces the set by 59% and 
final set consists 1628 binding site pairs. The pipeline of the binding site similarity 
analysis is shown in Figure 2.2. 
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                      Figure 2.2: Pipeline of the binding site similarity analysis (Haupt et al., 2013)  
 
1628 out of the 3948 target pairs (41%) have a similar binding site according to the 
alignment by SMAP together with the scoring with LigandRMSD. The average 
sequence identity of these 1628 target pairs is still low with 28% and the majority 
(1112 pairs) has less than 30% sequence identity. Taking a drug-centric view, 71% of 
the drugs have at least one target pair with a similar binding site and that for 18% of 
the drugs all of their targets are similar. Conclusively, according to this research 
similar binding sites and structural similarity correlate with promiscuity. [11] 
 
There have been a number of approaches to computational drug repositioning, 
including similarity of side effects, similarity of gene expression profiles of different 
diseases and structural similarity of binding sites. Structural similarity of binding 
sites provides insight into the mode of action of the drug. Many researches of 
proteins have shown, that similar binding sites exist among different proteins and 
similar binding sites most likely bind to the same ligands. This observation can be 
exploited, using binding site comparison methods to find new targets for known 
drugs leading eventually to drug repositioning as shown in Figure 2.3. The 
examination of protein–drug interactions helps to understand drug modes of action 
and reduce drug doses. The identification of off-targets gives the opportunity to 
optimize drugs to gain a higher selectivity and thus reduce side effects. 
 
15 
      
        Figure 2.3: Drug repositioning (Haupt and Schroeder, 2011) 
 
The figure above represents the drug repositioning process using binding site 
similarity. Two proteins A and B have similar binding sites and thus can be aligned 
(C). The found binding site similarity suggests that the ligand (D) may also bind to 
the protein (B). This gives a candidate for drug repositioning. 
 
One of the reasons for drug promiscuity constitutes the similarity of binding sites 
among proteins. These proteins either belong to the same family, thus showing a 
similar tertiary structure, or are distinct in their overall structure. The binding site 
centric chemical space seems to become the new technique in structure-based drug 
discovery and together with the ever growing structural data in the PDB, gives the 
opportunity to extensively use protein structural data and thus to find new drug 
targets and candidate drugs for repositioning. This method aims to reveal structural 
similarity in protein binding site pairs, although not necessarily similar in sequence 
or fold. Searching the whole PDB for a specific binding site can identify unexpected 
potential off-targets right at the beginning of the drug discovery process. [12] 
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2.3 Alignment Algorithms for Binding Site Similarity 
The current algorithms for binding site comparison tools, allow the quantification of 
local similarity between protein structures. These algorithms are based mostly on 
geometrical comparisons. Basic thing in them is that they abstract from the binding 
site, converting it into a discrete simplified representation. Binding sites 
representation can be accomplished in many different ways such as pharmacophoric 
features, atoms or residues. These are represented by one or more points and are 
labeled according to their physicochemical or geometric properties and only surface 
residues are considered. The binding pockets of a protein are identified by the 
analysis of the surface. Thus, there are also some algorithms that analyze the 
complete protein surface. The points can be assigned grid-based or irregularly, 
represent parts of the residues, individual atoms or neighborhood properties. Such 
points are called features. The resulting feature patterns of two binding sites are then 
structurally aligned such that the number of matched features is optimized. The 
binding site features are either represented as geometric patterns or as numerical 
fingerprints. 
 
First of all, the local structural alignment algorithms create the reduced geometrical 
representation of the binding site. Thus, the complexity of the pair-wise comparison 
is reduced. After that, properties are assigned to the points and finally, the binding 
sites are aligned. The approaches for binding site alignment are the following: 
 
● Iterative search for the best translation/rotation. The largest alignment is 
considered best 
● Geometric matching 
● Geometric hashing, which maps all triangles similar in shape, regardless of 
their orientation, to identical or very close hash slots 
● Clique detection 
● SiteAlign, that based on the binding sites numerical fingerprints 
● Alignment-free binding site comparison [12] 
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2.3.1 Scoring Functions and Success Alignment 
The binding site alignment is evaluated through a scoring function. The scoring can 
be directly incorporated in the alignment process, excluding bad scoring alignments. 
A key influence to the score is the number of aligned points. Basic scores are:  
 
● Tanimoto-index (number of aligned features divided by the total number of 
features) 
● RMSD for geometry or other  properties 
● Amino acid substitution (identification of similar binding sites) 
● Normalization scores permit the ranking of different alignments of one query 
to different target binding sites. A possible normalization is dividing the 
target–query score by the query–query score. 
 
There are also three parameters which influence the success of the site alignment and 
are the following: a) resolution of the binding site, b) distance tolerance and c) the 
complexity of feature descriptors. Methods, which use a comprehensive 
representation, are more prone to false negatives, which is due to slight changes in 
the binding sites in comparison to Ca atom-based descriptions. [12] 
2.4 Similarity between 3D protein structures - Comparison of protein 
binding sites 
Quantification of local similarity between protein 3D structures is a promising tool in 
computer-aided drug design and prediction of biological function. Almost all 
computational methods are based on geometrical comparisons. Structure-based 
methods for local comparison of unrelated proteins typically use a simplified 
representation of cavity residues, by partitioning of the surface into small patches 
which are then treated as geometric patterns or numerical fingerprints.  
 
All the described methods are based on geometric pattern comparisons that follow 
the same three steps (Figure 2.4): a) the structures of the two proteins are parsed 
into meaningful 3D coordinates in order to reduce the complexity of the pairwise 
comparison, b) the two resulting patterns are structurally aligned using the 
transformation that produces the maximum number of equivalent points and c) a 
scoring function quantifies the similarity based on aligned features. 
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               Figure 2.4: Overview of the comparison of protein binding sites (Kellenberger et al., 2008) 
 
 
The methods that are based on geometric pattern comparisons are divided into two 
categories:  
 
1.  Simplified Representation of Protein Cavities. The basic assumption in the 
search for similarity between active sites is that only residues close to the 
surface need to be considered. These amino acids may directly or indirectly be 
involved in ligand recognition. All surface residues or only cavity-flanking 
residues are taken into account. The cavity is either deduced from the analysis 
of the protein surface shape or defined from the distance of cavity-lining 
residues to a co-crystallized ligand. Whereas the former method only selects 
solvent accessible surface residues, the latter method may include a few buried 
residues. Cavity residues are then transformed into either an irregular or a 
regular 3D arrangement of points. 
 
2. Geometric Search for the Best Structural Alignment. The similarity between 
the cavities of two proteins is always inferred from the best structural 
alignment of corresponding patterns. 
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a. iterative search for the best translation/rotation 
b. geometric matching  
c. geometric hashing (Figure 2.5 A) 
d. clique detection (Figure 2.5 B) [15] 
 
 
 
Figure 2.5 (A) Geometric hashing. Because of the inter-point distance threshold used to generate the triplets, no 
triangles include the far-right point. For the sake of clarity, no labels were associated to points. (B) Clique 
detection. In the graph definition, nodes are connected if closer than a distance threshold. Point’s properties are 
represented by different achromatic colors. (Kellenberger et al., 2008) 
 
2.5 Detection of structurally similar protein binding sites by local 
structural alignment 
Binding sites of protein structures are closely related to protein function. The 
identification of binding sites in proteins is essential to the understanding of their 
interactions with ligands and other proteins. Binding sites can retain conservation of 
sequence and structure. Even in the absence of obvious sequence similarity, 
structural similarity between two protein structures can imply common ancestry and 
a similar function, but it is also possible for structurally similar proteins to have 
different functions. Similar folding by itself does not necessarily imply evolutionary 
divergence. In the case of divergent evolution, similarity is due to the common origin, 
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such as accumulation of differences from homologous ancestral protein structures. 
The frequency of two different folds converging to a similar statistically significant 
side-chain pattern is ~1%. If a protein has a known 3D structure but no known 
function, inferences concerning function can be made by comparison to other 
proteins.  
 
The algorithm used for exploitation of locally similar 3D patterns of physicochemical 
properties on the surface of a protein for detection of binding sites that may lack 
sequence and global structural conservation, is ProBis. 
 
2.5.1 ProBis Algorithm 
ProBiS can identify protein–protein binding sites by searching for conserved protein 
surface structure and physicochemical properties in proteins with similar folds and 
permitting comparison of only a few structural neighbors. The method was 
conducted in following steps (Figure 2.6): 
 
A. A query protein structure (Q) whose structurally similar regions are to be 
detected is compared with each of ~23 000 non-redundant PDB structures 
(P). Residues on the surface of the proteins are represented as graphs with 
vertices and edges. Vertices that are separated by <15 Å are connected with 
edges.  
 
B. Proteins are represented as graphs of vertices and edges, are divided into n 
overlapping subgraphs, where n is the number of vertices in each protein 
graph. To find if two subgraphs represent similar parts of their respective 
protein surfaces, the two distance matrices are subtracted, and from the 
resulting difference matrix, a value of similarity is calculated. For each pair of 
query and database protein’s subgraphs conducted a graph.  
 
C. All sufficiently similar pairs of subgraphs that pass the filtering in the previous 
step, subjected to the more rigorous maximum clique procedure, which 
detects vertex-to-vertex correspondences between the two protein graphs 
being compared. Then, the algorithm finds a maximum clique in each product 
graph. 
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D. Each maximum clique is equivalent to a single structural alignment and 
superimposition of two compared proteins. The alignments are local, and 
allow superimposition of maximum numbers of two protein subgraph vertices. 
 
E. Steps A–D are repeated for each database protein and the resulting 
alignments and their scores are saved to a results database implemented on 
the MySQL platform.  
                                            
 
                                                    Figure 2.6: ProBis Algorithm (Konc and Janezic,2010) 
 
2.5.1.1 Scores for structural alignment which performed by ProBis 
Algorithm 
There are five distinct criteria that are applied to each structural alignment. They are 
used to measure the statistical and structural significance and to permit filtering out 
off insignificant alignments. Local structural alignments do not need to involve a 
large number of residues, thus the similarity that is detected could in fact be a 
frequently occurring 3D motif, having no relationship to common protein function. 
 
Score measures:  
● Surface vectors angle: for each of the two superimposed sets of vertices, an 
outer-pointing surface vector originating in the geometric center and 
constructed perpendicular to the surface of the protein  
● Surface patch RMSD: measures the shape similarity of the two superimposed 
surfaces patches 
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● Surface patch size: discard each structural alignment with fewer than ten 
vertices 
● E-value [13] 
 
 
2.6 Methods for ligand binding 
There are several and different computational methods for the detection and 
characterization of protein ligand-binding sites. These methods, are divιded in the 
following areas: functional site detection, whereby protein evolutionary information 
has been used to locate binding sites on the protein surface, functional site 
similarity, whereby structural similarity and three dimensional templates can be 
used to compare and classify and potentially locate new binding sites and ligand 
docking, which is being used to find and validate functional sites. [16] 
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3. Design 
3.1 System architecture 
Initially, our infrastructure takes as input a protein pair. Subsequently, we installed 
R language and SPRINT framework in each node. Also in each node we installed jdk, 
mpi, python, openbabel, pybel, rdkit and eigen. The illustration below (Figure 3.1) 
represents the system architecture: 
 
 
    Figure 3.1: System Architecture 
The details depicted in this figure are explained in what follows. 
3.2 Pre-requisites 
3.2.1 R language and SPRINT framework 
Initially, we installed R (programming language) in the system. R is a programming 
language and software environment for statistical computing and graphics. The R 
language is widely used among statisticians and data miners for developing statistical 
software and data analysis. [1] 
 
Subsequently, we installed the SPRINT framework. The original rationale for 
SPRINT is based on microarray analysis allowing the simultaneous measurement of 
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thousands to millions of genes or sequences across tens to thousands of different 
samples. The analysis of the resulting data tests the limits of existing bioinformatics 
computing infrastructure. A solution to this issue is to use High Performance 
Computing (HPC) systems, which contain many processors and more memory than 
desktop computer systems. Although these form the original basis of SPRINT, most 
of existing parallelized functions are in principle useful in any situation where a very 
large number of computations are carried out or where computations results in very 
large memory use. This framework allows the addition of parallelized functions to R 
to enable the easy exploitation of HPC systems. The Simple Parallel R INTerface 
(SPRINT) is a wrapper around such parallelized functions. SPRINT allows R users to 
concentrate on the research problems rather than the computation, while still 
allowing exploitation of HPC systems. [2] 
The following figure provides an overview of the SPRINT framework (3.2) 
 
 Figure 3.2: SPRINT framework (Source: http://www.ed.ac.uk/pathway-medicine/our-
research/dpmgroups/ghazal-group/pathway-informatics/sprint/prototype) 
 
 
As mentioned above SPRINT is a framework that makes parallel algorithms available 
to R users. It is designed to be relatively easy to extend and is made up of two 
components:  
 
● R<->SPRINT interface  
● the compute cluster itself 
 
Communication is accomplished via files. 
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The following figure represents the R<->SPRINT interface (3.3): 
 
 
Figure 3.3: R<->SPRINT interface (Source: http://lists.r-forge.r-project.org/pipermail/sprint-developer/2013-
August/000004.html) 
 
 
When the user starts R with SPRINT loaded, the compute cluster goes into a wait 
state. When R reaches a function that is in SPRINT, the SPRINT-R stub sends a 
command to SPRINT via MPI. The MPI message contains an enumeration code that 
represents a function, which forces SPRINT to wake up and execute that function. 
The idea behind SPRINT is to allow parallel processing of data from within R without 
being restrained by R. Functions created in SPRINT should have similar interfaces to 
the serial R equivalent. Data required by the parallelized function is also passed via 
MPI. The creator of the function is responsible for creating that data flow. 
Afterwards, the function created is also responsible for passing the data back to R. 
This does not have to be the result of the processing, it could be a file handle, or a 
simple error code. 
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To create a new SPRINT function, it is required: 
 
● creating an R stub (such that R can call the function) 
● the C equivalent of the R stub 
● the function to run in the computer cluster 
● finally, connecting the different parts [3] 
 
3.2.1.1 SPRINT Architecture  
The SPRINT framework is made of two core components: 
 
● An intelligent parallel harness that manages all access to the HPC resources 
hiding the complexity from the user. 
● A flexible library of parallelized R functions that can be easily extended by 
adding more functions. 
 
The parallelization model adopted is a task farm with a Master process controlling 
the execution of many Worker processes. All nodes are running R, executing the R 
script and loading the SPRINT library. When the SPRINT library has been loaded, 
the Master node takes charges of the execution. When the Master node encounters a 
parallel function, it distributes the work to be done amongst the available processes. 
The parallel harness uses C and MPI. The Master process coordinates the reading 
and writing to files which is performed simultaneously and in parallel by all worker 
processes using MPI/IO (Figure 3.4). 
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Figure 3.4: Architecture of SPRINT (Source: http://www.ed.ac.uk/pathway-medicine/our-
research/dpmgroups/ghazal-group/pathway-informatics/sprint/sprint) 
 
3.2.2 Message Passing Interface (MPI) 
Message Passing Interface (MPI) is a standardized and portable message-passing 
system designed by a group of researchers from academia and industry to function 
on a wide variety of parallel computers. The standard defines the syntax and 
semantics of a core of library routines useful to a wide range of users writing portable 
message-passing programs in different computer programming languages such as 
Fortran, C, C++ and Java. There are several well-tested and efficient 
implementations of MPI, including some that are free or in the public domain. These 
fostered the development of a parallel software industry, and encouraged 
development of portable and scalable large-scale parallel applications. [6] 
3.2.3 Python 
Python is a widely used general-purpose, high-level programming language. Its 
design philosophy emphasizes code readability, and its syntax allows programmers 
to express concepts in fewer lines of code than would be possible in languages such 
as C++ or Java. The language provides constructs intended to enable clear programs 
on both a small and large scale. [7] 
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3.2.4 OpenBabel 
Open Babel is a chemical toolbox designed to speak the many languages of chemical 
data. It’s an open, collaborative project allowing anyone to search, convert, analyze, 
or store data from molecular modeling, chemistry, solid-state materials, 
biochemistry, or related areas. Also, Open Babel is a project to facilitate the 
interconversion of chemical data from one format to another – including file formats 
of various types. [8] 
3.2.5 Pybel 
Pybel provides convenience functions and classes that make it simpler to use the 
Open Babel libraries from Python, especially for file input/output and for accessing 
the attributes of atoms and molecules. The Atom and Molecule classes used by Pybel 
can be converted to and from the OBAtom and OBMol used by the openbabel 
module. [9] 
3.2.6. RDKit 
A collection of cheminformatics and machine-learning software is written in C++ and 
Python. The core algorithms and data structures are written in C++. Wrappers are 
provided to use the toolkit from either Python or Java. Additionally, the RDKit 
distribution includes a PostgreSQL-based cartridge that allows molecules to be 
stored in relational database and retrieved via substructure and similarity searches. 
[10] 
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4. Implementation 
Inside SPRINT we implemented four (4) new functions that enable the orchestration 
of the pipeline in two levels of parallelization that allows the identification of the 
similarity between protein binding sites (BSS pipeline), either using the “broadcast” 
or “scatter-gather” MPI collective communication routines depending on the user’s 
input: 
 
● 2 functions for both levels of parallelization: MPI_Bcast 
● 2 functions for both levels of parallelization: MPI_Scatter - MPI_Gather 
 
To start the calculations and compare the two methods, we implemented R scripts 
inside SPRINT framework. Then, inside these scripts we created a matrix with 
proteins Id’s and for all possible combinations of pairs, extracted specific results by 
the execution of Binding Site Similarity (BSS) pipeline. In this point, it is important 
to mention that the parallelization of the pipeline is conducted in two levels and for 
this reason we created two scripts for each function. 
4.1 MPI_Bcast 
A broadcast is one of the standard collective communication techniques. During a 
broadcast, one process sends the same data to all processes in a communicator. One 
of the main uses of broadcasting is to send out user input to a parallel program, or 
send out configuration parameters to all processes. 
 
The communication pattern of a broadcast looks like this (Figure 4.1): 
 
Figure 4.1: MPI_Bcast 
 
In this example, process zero is the root process and it has the initial copy of data. All 
of the other processes receive the copy of data. 
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Although the root process and receiver processes do different jobs, they all call the 
same MPI_Bcast function. When the root process calls MPI_Bcast, the data variable 
will be sent to all other processes. When all of the receiver processes call MPI_Bcast, 
the data variable will be filled in with the data from the root process. 
4.1.1 MPI_Barrier 
One of the things that are important to mention about collective communication is 
that it implies asynchronization point among processes. This means that all 
processes must reach a point in their code before they begin executing again. 
 
MPI has a special function that is dedicated to synchronizing processes: 
 
MPI_Barrier(MPI_Comm communicator) 
 
The name of the function is quite descriptive - the function forms a barrier, and no 
processes in the communicator can pass the barrier until all of them call the function. 
Below is presented an illustration in which the horizontal axis represents execution 
of the program and the circles represent different processes (Figure 4.2): 
 
 
Figure 4.2: MPI_Barrier 
Process zero first calls MPI_Barrier at the first time snapshot (T 1). While process 
zero is hung up at the barrier, process one and three eventually make it (T 2). When 
process two finally makes it to the barrier (T 3), all of the processes then begin 
execution again (T 4). 
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MPI_Barrier can be useful for many things. One of the primary use of MPI_Barrier is 
to synchronize a program so that portions of the parallel code can be timed 
accurately. 
4.2 MPI_Scatter - MPI_Gather  
As mentioned above we created also one more function to compare the 
computational performance between the two parallelization strategies.   
4.2.1 An introduction to MPI_Scatter 
MPI_Scatter is a collective routine that is very similar to MPI_Bcast. MPI_Scatter 
involves a designated root process sending data to all processes in a communicator. 
MPI_Bcast sends the same piece of data to all processes while MPI_Scatter sends 
chunks of an array to different processes. 
 
Figure 4.3: MPI_Bcast vs MPI_Scatter 
In the illustration above (Figure 4.3), MPI_Bcast takes a single data element at the 
root process (the red box) and copies it to all other processes. MPI_Scatter takes an 
array of elements and distributes the elements in the order of process rank. The first 
element (in red) goes to process zero, the second element (in green) goes to process 
one, and so on. Although the root process (process zero) contains the entire array of 
data, MPI_Scatter will copy the appropriate element into the receiving buffer of the 
process. 
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4.2.2 An introduction to MPI_Gather 
MPI_Gather is the inverse of MPI_Scatter. Instead of spreading elements from one 
process to many processes, MPI_Gather takes elements from many processes and 
gathers them to one single process. Below, is a simple illustration of this algorithm 
(Figure 4.4). 
 
 
 
                Figure 4.4: MPI_Gather 
 
Similar to MPI_Scatter, MPI_Gather takes elements from each process and gathers 
them to the root process. The elements are ordered by the rank of the process from 
which they were received.  
It is important to mention, that we used MPI_Barrier in the case of second function 
(MPI_Scatter - MPI_Gather). 
4.3 R scripts that call MPI_Bcast and MPI_Scatter-MPI_Gather in both 
levels of parallelization 
Parallelization (broadcast) 
R script(Level-1) 
library("sprint")    // it loads SPRINT 
psmapbc(matrix(c(pairs of protein Id’s)))  // call function MPI_Bcast 
pterminate()  // terminate R 
quit() // quit R 
 
R script(Level-2) 
library("sprint")    // it loads SPRINT 
psmapbcV2(matrix(c(pairs of protein Id’s)))  // call function MPI_Bcast 
pterminate()  // terminate R 
quit() // quit R 
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Parallelization (scatter-gather) 
R script(Level-1) 
library("sprint")    // it loads SPRINT 
psmapSG(matrix(c(pairs of protein Id’s)))  // call function  MPI_Scatter-
MPI_Gather 
pterminate()  // terminate R 
quit() // quit R 
 
R script(Level-2) 
library("sprint")    // it loads SPRINT 
psmapSGV2(matrix(c(pairs of protein Id’s)))  // call function  
MPI_Scatter-MPI_Gather 
pterminate()  // terminate R 
quit() // quit R 
 
As we mentioned above, we implemented four new functions inside SPRINT 
framework called:  psmapbc(), psmapbcV2() for both levels of parallelization 
which use broadcast and psmapSG(), psmapSGV2() for both levels of 
parallelization which use scatter-gather. 
 
In general, these functions enable the orchestration of the pipeline that allows the 
identification of the similarity between protein binding sites. 
 
In practice, each of these functions receives an R matrix as input and implements the 
following steps: 
 
a) creates all unique combinations (pairs of doubles) of the matrix’ elements 
b) distributes the pairs to the available processes (either using the “broadcast” or 
“scatter” MPI collective communication routines depending on the user’s 
input) 
c) runs a C code in each of the nodes using each pair of doubles as input 
 
The interface and parameters to the function psmapbc are: 
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psmapbc (x) 
 
where: 
 x is an R matrix containing the set of elements. 
 
Value x contains the unique protein IDs. The IDs are described in the Protein Data 
Bank repository [18]. Furthermore, in the third step of the algorithm each process 
executes the binding site similarity algorithm (BSS). 
 
The interface and parameters described above are the same for the four functions 
and these have the role of coordinator of the entire process. The functions psmapbc() 
and psmapbcV2(), call smapbc() and smapbcV2() respectively that implement the 
third step and psmapSG(), psmapSV2() call smapSG() and smapSGV2() respectively 
that implement also the third step. 
4.4 Binding Site Similarity (BSS) pipeline 
The main plan is to conduct experiments based on the pipeline algorithms proposed 
by Haupt et al (2013) [11]. Below, it is presented an illustration of Binding Site 
Similarity (BSS) pipeline (Figure 4.5): 
 
 
Figure 4.5: Binding Site Similarity (BSS) pipeline 
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BSS is accomplished in following steps: 
● a protein pair is received as input 
● for each protein, informations are extracted from PDB (3D shapes, nucleic 
acids, complex assemblies, etc.) 
● SMAP is executed 
o ligands of each protein 
o best alignment of the two proteins 
o matching ligands pairs 
o transformations and rotations for matching the two proteins 
 
● matching is conducted at the level of ligands 
o check structural isomorphism per ligand pair (use of Pybel and 
Openbabel) 
o subtractive isomorphism (maximum common subgraph if there is no 
isomorphism for the protein pair) 
 
● ligand pairs of the two proteins are found and results for one pair with the 
minimum difference-maximum similarity are exported 
 
The Protein Data Bank (PDB) is a repository for the three-dimensional structural 
data of large biological molecules, such as proteins and nucleic acids. The data, are 
typically obtained by X-ray crystallography or NMR spectroscopy and are submitted 
by biologists and biochemists from around the world, and are freely accessible on the 
Internet via the websites of its member organizations (PDBe, PDBj and RCSB). [4] 
The original BSS code was written in Python with calls to Python library Pybel (and 
OpenBabel) and Java library SMAP. Binding Site Similarity (BSS) pipeline was 
originally designed to accept one protein pair and the execution conducted 
sequentially for specific ligands. Through our implementation, the execution 
accomplished for all the proteins is needed to be examined with all the possible 
ligand pairs and parallelized through our functions. 
4.5 Optimizations 
As we mentioned above we achieved to parallelize the BSS pipeline in two different 
levels. In first level, we parallelized the whole pipeline (protein alignment and ligand 
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similarity) and in second level, we parallelized the slow parts of the pipeline (ligand 
matching). 
4.5.1 First level of parallelization 
We have wrapped the code for BSS pipeline (protein pair similarity) in SPRINT 
functions (blue box), that take as input a list of protein’s pairs ids and examine each 
pair in a parallel thread. This is illustrated below (Figure 4.6): 
 
 
Figure 4.6: First level of parallelization 
 
4.5.2 Second level of parallelization 
We have parallelized the slow parts of BSS pipeline (ligand matching). We have 
modified the code for binding site similarity (green box) to examine each ligand pair 
in a separate thread. This is illustrated below (Figure 4.7): 
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Figure 4.7: Second level of parallelization 
 
For the need of this parallelization we use Python C-API. The Application 
Programmer’s Interface to Python gives C and C++ programmers access to the 
Python interpreter at a variety of levels. The API is equally usable from C++, but for 
brevity it is generally referred to as the Python/C API. There are two fundamentally 
different reasons for using the Python/C API. The first reason is to write extension 
modules for specific purposes; these are C modules that extend the Python 
interpreter. The second reason is to use Python as a component in a larger 
application; this technique is generally referred to as embedding Python in an 
application. [5] 
 
4.5.3 Implemented parallelization alternatives in SPRINT 
We wrapped everything in SPRINT functions. The functions that we have created 
(MPI_Bcast, MPI_Scatter - MPI_Gather) execute each level of parallelization.  
 
In Figure 4.8, are presented the two functions (psmapbc, psmapbcV2 -> broadcast) 
that parallelize the levels of BSS pipeline (psmabc for Level 1, psmapbcV2 for Level 
2). 
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Figure 4.8:  Functions (broadcast) that parallelize the two levels of BSS pipeline 
 
 
In Figure 4.9, are represented the two functions (psmapSG, psmapSGV2 -> scatter-
gather) that parallelize the levels of BSS pipeline (psmapSG for Level 1, psmapSGV2 
for Level 2). 
 
 
 
Figure 4.9:  Functions (scatter-gather) that parallelize the two levels of BSS pipeline 
 
39 
5. Experiments - Results 
5.1 Dataset description 
For the purpose of experiments, we used six proteins ids (1iei, 1z89, 3p2v, 3kwb, 
2bdl, 2auz) and according to mathematic formula (n^2 - n)/2, 15 unique 
combinations of protein pairs were finally extracted.  
Figure 5.1 below represents the number of ligands combination per protein pairs. 
 
 
Figure 5.1: Number of ligands combination per protein pairs 
 
Figure 5.2 represents the functions that used for ligand comparison. 
 
Figure 5.2: Isomorphism and MCS function calls per ligand pair 
In the Βinding Site Similarity code there are two functions that perform ligand 
comparison for the protein pairs. These are findIso() that finds all isomorphisms 
between the target and the query mol and findMCS() that performs substructure 
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search if there is not isomorphism. In effect, this function computes the maximum 
common subgraph of the two molecules and finds substructure isomorphisms. 
5.2 One node setup - Laptop vs okeanos 1 machine 
In order to compare the results of our experiments, we execute the BSS pipeline 
(both levels of parallelization) in our machine but we also use okeanos infrastructure. 
In this infrastructure it is possible to create virtual machines and particularly 
constitutes a IaaS Service. "IaaS" stands for "Infrastructure as a Service", and it 
means that anyone can build virtual machines (computers), always connected to the 
Internet, without problems such as hardware failures, spaghetti cables, connectivity 
hiccups and software troubles. 
5.2.1 Configuration of machines 
Laptop configuration: 
●  OS: Ubuntu Desktop 14.04 LTS 
● 4 GB RAM 
● 2 CPUs 
 
Okeanos 1 machine configuration: 
● OS: Ubuntu Server 14.04 LTS 
● 6 GB RAM 
● 4 CPUs 
 
5.2.2 Single Node – 1st level of parallelization 
In this experiment, we measure the average time (5 runs) needed for the execution of 
the whole pipeline for 15 protein pairs. We implement the 1st level of parallelization 
in which each protein pair is processed in a separate thread using broadcast. The 
times reported in Table 1 are measured in the laptop using 4 threads. 
 
 
Table 1.  Results of single node – 1st level of parallelization experiment 
EXECUTIONS TIME(seconds) 
1 225,392034  
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2 224,697258  
3 225,952008 
4 229,972001  
5 228,372237 
Average time 226,8771076±1.94 at 95% CI 
 
From the results of Table 1, we see that the worst execution time for the 15 protein 
pairs is a bit less than 4 minutes. 
5.2.3 Single Node – 2nd level of parallelization 
 
Table 2. Results of single node – 2nd level of parallelization experiment 
EXECUTIONS TIME(seconds) 
1 208,757258 
2 208,045365 
3  207,767564 
4 209,978678 
5 207,857208 
Average time 208,48122±0.81 at 95% CI 
 
From the results we can see that the 2nd level of parallelization offers a significant 
improvement in execution time, at the level of 8% of the initial time, with the same 
hardware setup.  
5.2.4 Single Node Okeanos – 1st level of parallelization 
In this experiment, we measure the average time (5 runs) needed for the execution of 
the whole pipeline for 15 protein pairs. We implement the 1st level of parallelization 
in which each protein pair is processed in a separate thread using broadcast. The 
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times reported in Table 3 are measured in the okeanos infrastructure using 4 threads 
and 4 CPUs. 
 
Table 3. Results of single node in okeanos – 1st level of parallelization experiment 
EXECUTIONS TIME(seconds) 
1 165,289306 
2 165,603692 
3 166,597197 
4 164,852996 
5 167,377057 
Average time 165,9440496±0.9  at 95% CI 
 
From the results we can see that the 1st level of parallelization in okeanos 
infrastructure offers a significant improvement in execution time, compared with 
laptop setup. This is because in okeanos, we have more resources and data spread 
over several CPUs. 
5.2.5  Single Node Okeanos – 2nd level of parallelization 
 
Table 4. Results of single node okeanos – 2nd level of parallelization experiment 
EXECUTIONS TIME(seconds) 
1 148,991805 
2 147,961708  
3 148,786597 
4 147,564523 
5 148,453654 
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Average time 147,84±0.52  at 95% CI 
 
 
From the results we can see that the 2nd level of parallelization in okeanos, offers the 
best improvement in execution time. We observe that the execution time compared 
with laptop single node 2nd level of parallelization, offers a significant improvement 
in execution time, at the level of 28%. 
5.2.6 Discussion of results 
Figure 5.3 illustrates the time comparisons between Laptop - Okeanos setups in 
second level of parallelization. 
 
 
 
 
Figure 5.3: Time comparison in second level of parallelization 
 
Figure 5.4 illustrates the average time comparisons between Laptop - Okeanos 
setups, in both levels of parallelization. 
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                                        Figure 5.4: Average time comparisons in both levels of parallelization 
 
As we see in the above figures the execution time between the two levels of 
parallelization is dropping significantly. This is because in the second level, we have 
parallelized the slow parts of BSS pipeline (ligand matching). 
 
Also in okeanos setup we see important reduction of time execution in both 
parallelizations versus laptop setup, because the infrastructure is implemented with 
4 CPUs.  
 
Figure 5.5 illustrates the elapsed time of the whole process but also the time of 
findIso() and findMCS(). For this experiment, we used the second level of 
parallelization in okeanos infrastructure.  
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         Figure 5.5: Elapsed time findIso() vs findMCS() vs Total_time of the remaining processing 
 
 
 
Figure 5.6 illustrates the elapsed time of the whole process but also the time of 
findIso() and findMCS(), for one protein pair (1ei3,1z89). In this figure it is clear how 
much time is consumed for the execution of the functions for ligand comparison. 
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Figure 5.6: Elapsed time 
findIso() vs findMCS() vs Total time of the remaining processing for one protein pair (1iei,1z89) 
 
The total runs of findMCS() and findIso(), used for ligand comparison is 79. The total 
runs of function findMCS() is 3 and the total runs of function findIso() is 76. 
 
From the above diagrams, we can see that 3 runs of the function findMCS() occupies 
3% of the total time of the remaining processing which is 97,77 %, ie approximately 
4,8 seconds. On the other hand, we observe that 76 runs of the function findIso() 
occupies 35% of the total time of the remaining processing, ie approximately 52 
seconds. 
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6. Conclusion  
As we mentioned above, drug repositioning process makes use of technologies and 
algorithms based on sequential programming.  
 
Over the years there has been increasing data that they need treatment and study in 
the field of polypharmacology. This leads to the need for parallel programming 
technologies. As a result, we achieved to parallelize this process, namely the Binding 
Site Similarity pipeline. 
 
Summarizing the results of this thesis, through our architecture and technology 
implementation, the accuracy and performance of the system was improved. 
 
As noticed by the results of experiments, the execution time of both parallelization is 
reduced, when we ran our experiments on Okeanos using more cores. Ie the more 
resources used, the better runtime had. Also it was observed significant differences 
between the time between the two levels of parallelization. In first level, we 
parallelized the whole pipeline (protein alignment and ligand similarity) and in 
second level, we parallelized the slow parts of the pipeline (ligand matching). We 
noticed a reduction of around 50%, something which is a significant result in 
performance. 
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6.1 Future Work 
As observed from the experiments carried out, there are points in our 
implementation that present bottlenecks. For example a large part of the total time, 
occupied downloading the proteins we want to examine from the PDB. One possible 
solution is to save the files to a local repository once before the implementation of 
BSS pipeline, and pull from there the data needed each time. 
 
Also we aim to adapt to existing implementation, the ProBis algorithm. Unlike SMAP 
performed sequence alignment and exported among others translation and rotations 
for the proteins, PROBIS performs four times this process and selects the best case, 
ie does not take into consideration ligands that their distances are far ( according P-
VALUE). 
 
Furthermore as we have seen from our experiments a large part of the overall process 
occupies the functions findMCS() and findIso(). As mentioned above, at the level of 
ligand matching performed two functions. FindIso() that finds all isomorphisms 
between the target and the query mol and findMCS() that performs substructure 
search if there is not isomorphism. In effect, this function computes the maximum 
common subgraph of the two molecules and finds substructure isomorphisms. There 
would be important to see, what information can be cached regarding the molecules 
contemplated, so that upon the execution of these functions be not extracted 
information all over again for the same ligands. In this way, we believe that the 
execution time will improve. 
 
Moreover, within the next few months we aim to implement one more function in the 
SPRINT framework for clustering purposes. The method will implement a 
parallelized version of the popular hierarchical agglomerative clustering (HAC) 
algorithm. In comparison to partitioning algorithms (e.g. k-medoids, PAM), HAC 
produces a hierarchy of clustering schemes as output.  
The implementation will be based on PINK, a distributed-memory parallel algorithm 
through solving the minimum spanning tree problem with Prim's algorithm. PINK, is 
described in "A Scalable Algorithm for Single-Linkage Hierarchical Clustering on 
Distributed-Memory Architectures". [17] Among others, we plan to compare the 
results of ppam against the HAC implementation on SPRINT. 
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